---
title: "SONOSCAPE released its first-quarter performance, with a net profit attributable to the parent company of 8.0746 million yuan, a decrease of 91.94%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/237538789.md"
description: "According to the Zhitong Finance APP, SONOSCAPE released its first-quarter report for 2025, showing an operating revenue of 430 million yuan, a year-on-year decrease of 10.29%. The net profit attributable to shareholders of the listed company was 8.0746 million yuan, a year-on-year decrease of 91.94%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 5.9981 million yuan, a year-on-year decrease of 93.49%. The basic earnings per share were 0.0187 yuan"
datetime: "2025-04-25T08:59:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/237538789.md)
  - [en](https://longbridge.com/en/news/237538789.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/237538789.md)
generator: "portal-rs"
---

# SONOSCAPE released its first-quarter performance, with a net profit attributable to the parent company of 8.0746 million yuan, a decrease of 91.94%

According to the Zhitong Finance APP, SONOSCAPE (300633.SZ) released its first quarter report for 2025, with operating revenue of 430 million yuan, a year-on-year decrease of 10.29%. The net profit attributable to shareholders of the listed company was 8.0746 million yuan, a year-on-year decrease of 91.94%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 5.9981 million yuan, a year-on-year decrease of 93.49%. The basic earnings per share were 0.0187 yuan

### Related Stocks

- [300633.CN](https://longbridge.com/en/quote/300633.CN.md)

## Related News & Research

- [Viromed Medical’s Heike Perbandt, closely associated with managing body member Uwe Perbandt, sells shares for EUR 52,000](https://longbridge.com/en/news/298227013.md)
- [NGEx Minerals to host investor day webcast](https://longbridge.com/en/news/298297598.md)
- [SynAct Pharma bolsters resomelagon data as it readies Phase 3 and weighs strategic deals](https://longbridge.com/en/news/298195637.md)
- [Neuro Event Labs wins CMS NTAP coverage for Nelli seizure monitoring system, up to USD 975 per case](https://longbridge.com/en/news/298310708.md)
- [Grass Valley showcases new Framelight X workflow capabilities at IBC2026](https://longbridge.com/en/news/298178097.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**